Building on these findings, we hypothesized that the phosphorylated form of PKM2 at tyrosine 105 (pY105-PKM2), a known driver of tumor stemness, could contribute to the transmission of stem-like traits via sEVs, thereby replenishing the CSC pool. The gene discussed is PKM; the disease is neoplasm.